Guava leaf extracts promote glucose metabolism in SHRSP.Z-Leprfa/Izm rats by improving insulin resistance in skeletal muscle

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Guo, Xiangyu ^a   Yoshitomi, Hisae ^b   Gao, Ming ^b   Qin, Lingling ^a   Duan, Ying ^c   Sun, Wen ^a   Xu, Tunhai ^a   Xie, Peifeng ^a   Zhou, Jingxin ^a   Huang, Liansha ^a   Liu, Tonghua ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN RECEPTOR 1; GLUCOSE; GLUCOSE TRANSPORTER 4; GUAVA EXTRACT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GUAVA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NONHUMAN; PLANT LEAF; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SKELETAL MUSCLE;

ANIMALS; AREA UNDER CURVE; BLOOD GLUCOSE; BODY WEIGHT; CELL MEMBRANE; DISEASE MODELS, ANIMAL; GLUCOSE TRANSPORTER TYPE 4; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MUSCLE, SKELETAL; PHOSPHORYLATION; PLANT EXTRACTS; PLANT LEAVES; PROTO-ONCOGENE PROTEINS C-AKT; PSIDIUM; RATS; RATS, INBRED STRAINS; SIGNAL TRANSDUCTION;

EID: 84874396966     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-52     Document Type: Article

References (34)

1. Ford ES. Prevalence of the metabolic syndrome defined by the international diabetes federation among adults in the U.S. Diabetes Care 2005, 28(11):2745-2749. 10.2337/diacare.28.11.2745, 16249550.
2. Zheng Y, Stein R, Kwan T, Yu C, Kwan J, Chen S-L, Hu D. Evolving cardiovascular disease prevalence, mortality, risk factors, and the metabolic syndrome in China. Clin Cardiol 2009, 32(9):491-497. 10.1002/clc.20605, 19743493.
3. Defronzo RA, Gunnarsson R, Bjorkman O, Olsson M, Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 1985, 76(1):149-155. 10.1172/JCI111938, 423730, 3894418.
4. White MF. IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 2002, 283(3):E413-E422.
5. Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, DeFronzo RA, Kahn CR, Mandarino LJ. Insulin resistance differentially affects the PI3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000, 105(3):311-320. 10.1172/JCI7535, 377440, 10675357.
6. Ginsberg HN, MacCallum PR. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. J Cardiometab Syndr 2009, 4(2):113-119. 10.1111/j.1559-4572.2008.00044.x, 2901596, 19614799.
7. Goldstein BJ, Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004, 89(6):2563-2568. 10.1210/jc.2004-0518, 15181024.
8. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257(1):79-83. 10.1006/bbrc.1999.0255, 10092513.
9. Owen PL, Martineau LC, Caves D, Haddad PS, Matainaho T, Johns T. Consumption of guava (Psidium guajava L) and noni (Morinda citrifolia L) may protect betel quid-chewing Papua New Guineans against diabetes. Asia Pac J Clin Nutr 2008, 17(4):635-643.
10. Ernst E. Plants with hypoglycemic activity in humans. Phytomedicine 1997, 4(1):73-78. 10.1016/S0944-7113(97)80031-1, 23195249.
11. Ojewole JAO. Hypoglycemic and hypotensive effects of Psidium guajava Linn. (Myrtaceae) leaf aqueous extract. Methods Find Exp Clin Pharmacol 2005, 27(10):689-695. 10.1358/mf.2005.27.10.948917, 16395418.
12. Oh WK, Lee CH, Lee MS, Bae EY, Sohn CB, Oh H, Kim BY, Ahn JS. Antidiabetic effects of extracts from Psidium guajava. J Ethnopharmacol 2005, 96(3):411-415. 10.1016/j.jep.2004.09.041, 15619559.
13. Cheng F-C, Shen S-C, Wu JS-B. Effect of guava (Psidium guajava L.) leaf extract on glucose uptake in rat hepatocytes. J Food Sci 2009, 74(5):H132-H138. 10.1111/j.1750-3841.2009.01149.x, 19646046.
14. Shen S-C, Cheng F-C, Wu N-J. Effect of guava (Psidium guajava Linn.) leaf soluble solids on glucose metabolism in type 2 diabetic rats. Phytother Res 2008, 22(11):1458-1464. 10.1002/ptr.2476, 18819164.
15. Deguchi Y, Miyazaki K. Anti-hyperglycemic and anti-hyperlipidemic effects of guava leaf extract. Nutr Metab 2010, 7:9.
16. Hiraoka-Yamamoto J, Nara Y, Yasui N, Onobayashi Y, Tsuchikura S, Ikeda K. Establishment of a new animal model of metabolic syndrome: SHRSP fatty (fa/fa) rats. Clin Exp Pharmacol Physiol 2004, 31(1-2):107-109.
17. Qian H, Nihorimbere V. Antioxidant power of phytochemicals from Psidium guajava leaf. J Zhejiang Univ Sci 2004, 5(6):676-683. 10.1631/jzus.2004.0676, 15101101.
18. Koch TR, Nipper HC. Evaluation of automated glucose oxidase methods for serum glucose: comparison to hexokinase of a colorimetric and an electrometric method. Clin Chim Acta 1977, 78(2):315-322. 10.1016/0009-8981(77)90322-9, 884863.
19. van Hoek M, Langendonk JG, de Rooij SR, Sijbrands EJG, Roseboom TJ. Genetic variant in the IGF2BP2 gene may interact with fetal malnutrition to affect glucose metabolism. Diabetes 2009, 58(6):1440-1444. 10.2337/db08-1173, 2682678, 19258437.
20. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85(7):2402-2410. 10.1210/jc.85.7.2402, 10902785.
21. Boura-Halfon S, Zick Y. Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab 2009, 296(4):E581-E591. 10.1152/ajpendo.90437.2008, 18728222.
22. Kim YB, Nikoulina SE, Ciaraldi TP, Henry RR, Kahn BB. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest 1999, 104(6):733-741. 10.1172/JCI6928, 408433, 10491408.
23. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000, 20(6):1595-1599. 10.1161/01.ATV.20.6.1595, 10845877.
24. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7(8):941-946. 10.1038/90984, 11479627.
25. Abdul-Ghani MA, DeFronzo RA. Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol 2010, 2010:476279. 2860140, 20445742.
26. Yoshitomi H, Guo X, Liu T, Gao M. Guava leaf extracts alleviate fatty liver via expression of adiponectin receptors in SHRSP.Z-Leprfa/Izm rats. Nutr Metab (Lond) 2012, 9:13.
27. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Medical Clinics of North America 2004, 88(4):787-835. ix, 10.1016/j.mcna.2004.04.013, 15308380.
28. Shepherd PR, Kahn BB. Mechanisms of disease - glucose transporters and insulin action - implications for insulin resistance and diabetes mellitus. N Eng J Med 1999, 341(4):248-257.
29. Wedick NM, Snijder MB, Dekker JM, Heine RJ, Stehouwer CDA, Nijpels G, van Dam RM. Prospective investigation of metabolic characteristics in relation to weight gain in older adults: the Hoorn Study. Obesity 2009, 17(8):1609-1614. 10.1038/oby.2008.666, 19197256.
30. Phillips DIW, Caddy S, Ilic V, Fielding BA, Frayn KN, Borthwick AC, Taylor R. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metab Clin Exp 1996, 45(8):947-950. 10.1016/S0026-0495(96)90260-7, 8769349.
31. Turcotte LP, Swenberger JR, Tucker MZ, Yee AJ. Increased fatty acid uptake and altered fatty acid metabolism in insulin-resistant muscle of obese Zucker rats. Diabetes 2001, 50(6):1389-1396. 10.2337/diabetes.50.6.1389, 11375340.
32. Houmard JA, Pories WJ, Dohm GL. Is there a metabolic program in the skeletal muscle of obese individuals?. Journal of Obesity 2011, 2011:250496. 3092539, 21603262.
33. Shimabukuro M, Koyama K, Chen G, Wang M-Y, Trieu F, Lee Y, Newgard CB, Unger RH. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 1997, 94(9):4637-4641. 10.1073/pnas.94.9.4637, 20776, 9114043.
34. Viollet B, Lantier L, Devin-Leclerc J, Hebrard S, Amouyal C, Mounier R, Foretz M, Andreelli F. Targeting the AMPK pathway for the treatment of Type 2 diabetes. Frontiers in bioscience: a journal and virtual library 2009, 14:3380-3400.